期刊文献+

多发性骨髓瘤患者骨髓基质细胞IL-1β、IL-6、SCF、TPO表达的研究 被引量:3

Expressions of IL-1β,IL-6,SCF,TPO on bone marrow stromal cells in patients with multiple myelo-ma
全文增补中
导出
摘要 目的研究多发性骨髓瘤(MM)患者骨髓基质细胞多种细胞因子在 mRNA 水平的表达情况,探讨不同因子在 MM 发生、发展中可能存在的作用。方法采用半定量 RT-PCR 方法在 mRNA 水平上检测 MM 患者骨髓基质细胞白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、干细胞因子(SCF)、血小板生成素(TPO)的表达。结果 IL-1B、IL-6的表达:MM 组与正常对照组和非 MM 组相比差异均具有统计学意义(P<0.01)。SCF 的表达:自体移植后患者组与正常对照组相比差异无统计学意义(P>0.05),初发 MM 组和难治复发 MM 组与正常对照组和非 MM 组相比差异均有统计学意义(P<0.05)。TPO 的表达:MM 组与正常对照组相比差异具有统计学意义(其中初发组 P<0.01,其余两组 P<0.05)。初发组与非 MM 组相比差异有统计学意义(P<0.01),难治复发 MM 组和移植后患者组与非 MM 组相比差异无统计学意义。结论体外培养的 MM 患者骨髓基质细胞 IL-1β、IL-6、SCF 和 TPO 存在表达异常,这些因子在疾病进展中可能起重要作用。 Objective To study multiple cytokine mRNA expressions of bone marrow stromal cells in patients with multiple myeloma(MM),as well as to explore the role of these cytokines in the occurrence and development of MM.Methods Semi-quantitiative RT-PCR was used to detect the mRNA expressions of IL- 1β,IL-6,SCF,TPO.Results The mRNA expression levels of IL-1β and IL-6 were higher than that of nor- mal controls and other hematological malignancies(P<0.01). For the expression of SCF, except the trans- planted MM patients,there was a significant difference when other MM patients contrast to the normal controls and other hematological malignancies(P<0.05).For the expression of TPO,there was a significant difference between the MM patients and the normal controls and between the primary MM and other hematological malig- nancies(P<0.01).There was not a significant difference when the relapsed MM and the auto-transplanted MM contrasted to other hematological malignancies.Conclusion IL-1β,IL-6,SCF and TPO on stromal cells are up-regulated at mRNA level when cultured in vitro and may play an important role in the disease pathogenesis.
出处 《肿瘤研究与临床》 CAS 2007年第11期732-734,738,共4页 Cancer Research and Clinic
关键词 多发性骨髓瘤 骨髓微环境 骨髓基质细胞 细胞因子类 RT-PCR Multiple myeloma Bone marrow microenvironment Bone marrow stromal cells Cytokine RT-PCR
  • 相关文献

参考文献8

  • 1朱光荣,周小玉,陆化,周建伟,李爱萍,徐卫,李建勇,汪承亚.人骨髓间充质干细胞表达多种造血细胞因子[J].中国实验血液学杂志,2003,11(2):115-119. 被引量:28
  • 2张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 3Adnan A,David H.Multiple myeloma:an old disease with new hope for the future. CA A Cancer Journal for Clinicians . 2002 被引量:1
  • 4Vidriales MB,Anderson KC.Adhension of multiple myeloma cells to the bone marrow microenviroment:implications for future therapeutic strategies. Molecular Medicine Today . 1996 被引量:1
  • 5Wallace S R,Oken M M,Lunetta K L,et al.Abnormalities of Bone Marrow Mesenchymal Cells in MultipleMyelomaPatients. Cancer . 2002 被引量:1
  • 6Alsina M,Gerbino E,Painter J,et al.The effects of interleukin-6(IL-6) on myeloma cell adhesion to fibronectin(FN) are mediated by macrophage inflammatory protein-1 a, (MIP-1α). Blood . 2001 被引量:1
  • 7Urashima M,Chen BP,Chen S,et al.The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood . 1997 被引量:1
  • 8Chaudhary,LR,Spelsberg,TC,Riggs,BL.Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and TNF-α: lack of regulation by 17β-estradiol. The Journal of Endocrinology . 1992 被引量:1

二级参考文献17

  • 1[1]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284: 143-147 被引量:1
  • 2[2]Chaudhary LR, Spelsberg TC, Riggs BL. Production of various cytokines by normal human osteoblast-like cells in response to IL1β and tumor necrosis factorα. Endocrinology, 1997; 130:2528-2534 被引量:1
  • 3[3]Koc ON, Gerson SL, Cooper BW, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol, 2000; 18: 307-316 被引量:1
  • 4[4]Majumdar MK, Thiede MA, Haynesworth SE, et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res, 2000; 9:841-848 被引量:1
  • 5[5]Haynesworth SE, Baber MA, Caplan AI, et al. Cytokine expression by human marrow-derived mesenchymal progenitor in vitro: effects of dexamethasone and IL-1α. J Cell Physiol, 1998; 166:585-592 被引量:1
  • 6[6]Dormady SP, Bashayan O, Dougherty R, et al. Immortalized multipotential messenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res, 2001; 10:125-140 被引量:1
  • 7[7]Majumdar MK, Thiede MA, Mosca JD. et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol, 1998; 176:57-66 被引量:1
  • 8[8]Broudy VC. Stem cell factor and hematopoiessis. Blood, 1997; 90:1345-1364 被引量:1
  • 9[9]Panzenbock B, Bantunek P, Mapara MY, et al. Growth and differentiation of human stem cell factor/erythropoietin dependent erythroid progenitor cell in vitro. Blood, 1998; 92:3658-3668 被引量:1
  • 10[10]Westwood NB, Chuny R, Emmerson A, et al. The in vitro effects of stem cell factor, interleukin-3 and granulocyte-macrophage colony stimulating factor on haemapoietic progenitor cells from premature infants. Br J Haematol, 1994; 86:468-474 被引量:1

共引文献27

同被引文献21

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部